Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2012-03-30 Major Shareholding Noti…
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
13G/A
Major Shareholding Notification
2012-03-30 English
BOVIE MEDICAL CORPORATION 10K 12-31-2011
Annual Report FY 2011
2012-03-29 English
BOVIE 8-K RE: SHAREHOLDER MEETING
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated March 22, 2012, by Bovie Medical Corporation. It announces the date for the 2012 Annual Meeting of Stockholders, the record date for voting, and information about proxy materials mailing and shareholder nomination deadlines. The content focuses on shareholder meeting scheduling and related procedural information rather than the meeting materials themselves or voting results. The document is short (3102 characters) and serves as an announcement of shareholder meeting details, not the meeting presentation or voting results. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories like AGM Information or Declaration of Voting Results.
2012-03-28 English
13G/A
Major Shareholding Notification
2012-03-20 English
BOVIE 8-K RE: SETTLEMENT AGREEMENT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a settlement agreement related to pending litigations, detailing terms of payments, intellectual property transfers, and dismissals of lawsuits. It does not contain financial statements or detailed financial performance data but rather reports a significant legal and business event. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like legal proceedings report (LTR) because it is primarily about a settlement agreement disclosure in an 8-K form. The document length and detail also support this classification rather than a brief announcement or a full legal proceeding report.
2012-02-28 English
13G/A
Major Shareholding Notification
2012-02-03 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.